Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
Maryam Nakhjavani1,2, Jennifer E Hardingham3,4, Helen M Palethorpe5,6
1Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. maryam.nakhjavani@adelaide.edu.au.
Abstract:
Breast cancer is still one of the most prevalent cancers and a leading cause of cancer death worldwide. The key challenge with cancer treatment is the choice of the best therapeutic agents with the least possible toxicities on the patient. Recently, attention has been drawn to herbal compounds, in particular ginsenosides, extracted from the root of the Ginseng plant. In various studies, significant anti-cancer properties of ginsenosides have been reported in different cancers. The mode of action of ginsenoside Rg3 (Rg3) in in vitro and in vivo breast cancer models and its value as an anti-cancer treatment for breast cancer will be reviewed.
Insights
Ginsenosides, compounds from Ginseng root, show significant anti-cancer properties. This review focuses on ginsenoside Rg3
Area of Science:
- Oncology
- Pharmacology
- Natural Products
Background:
- Breast cancer remains a leading cause of cancer death globally.
- Developing effective treatments with minimal patient toxicity is crucial.
- Herbal compounds, specifically ginsenosides from Ginseng, are gaining attention for their therapeutic potential.
Purpose of the Study:
- To review the anti-cancer properties of ginsenosides.
- To examine the mode of action of ginsenoside Rg3 (Rg3) in breast cancer.
- To evaluate Rg3's potential as an anti-cancer treatment for breast cancer.
Main Methods:
- Literature review of existing studies.
- Analysis of *in vitro* breast cancer models.
- Analysis of *in vivo* breast cancer models.
Main Results:
- Ginsenosides exhibit significant anti-cancer properties across various cancer types.
- Ginsenoside Rg3 demonstrates specific anti-cancer effects in breast cancer models.
- The review synthesizes data on Rg3's mechanism of action and therapeutic value.
Conclusions:
- Ginsenoside Rg3 shows promise as a potential therapeutic agent for breast cancer.
- Further research into Rg3's efficacy and safety is warranted.
- Natural compounds like Rg3 offer a potential avenue for novel breast cancer treatments.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Indicators
Targeted Cancer Therapies
There are several types of targeted therapies against...
Therapeutic Index
Molecular Models
Molecular Shape and Polarity


